Seems strange that the BOD would be wasting their time trailing a drug that has no commercial outcomes. Especially as these initial results have exceeded even their own expectations... that would suggest 42x has had no potential from the very outset.
Will agree to disagree with you
Ann: IHL-42X phase 2 clinical trial presentation, page-51
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)